Ruxolitinib inhibits poly(I:C) and type 2 cytokines-induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma.
Citation
Immunity, inflammation and disease; 2021 Jun; 9(2) pg363-373
Navigate to the CSV file of PeproTech products on your computer. Click on the file name to highlight it. Then, click "Open" in the dialog box. Items will load on the Quick Order form.